Core Viewpoint - Tianyi Medical (301097) has announced a significant decline in its expected net profit for the fiscal year 2025, projecting a loss between 18 million to 11 million yuan, marking a drastic decrease of 1,378.49% to 2,319.35% compared to the previous year [1] Financial Performance - As of February 2, 2026, Tianyi Medical's stock closed at 57.11 yuan, down 4.71% from the previous trading day, with a total market capitalization of 3.366 billion yuan [1] - The stock opened at 57.8 yuan, reached a high of 59.2 yuan, and a low of 55.13 yuan, with a trading volume of 1.44 billion yuan and a turnover rate of 8.74% [1] Earnings Forecast - The company expects a net profit attributable to shareholders to be between -18 million to -11 million yuan for 2025, indicating a substantial decline from the previous year's performance [1] - The forecasted net profit after excluding non-recurring gains and losses is anticipated to be between -13 million to -8 million yuan [1] - The decline in performance is attributed to several factors, including the provision for administrative penalties, investment losses from the integration of the CRRT business, increased foreign exchange losses due to fluctuations in the US dollar, and increased provisions for inventory impairment [1]
天益医疗（301097）披露2025年度业绩预告，2月2日股价下跌4.71%